Medical DevicesLast reviewed April 2026

Human Factors Engineering(HFE)

The application of usability knowledge to medical device design to minimize use-related hazards and support safe, effective operation.

Usage Examples

Formative usability studies identified five use errors addressed through interface redesign before validation.
HFE validation tested 30 representative users performing 12 critical tasks under simulated use conditions.

What is HFE?

Human Factors Engineering (HFE) — also called usability engineering — applies knowledge of human capabilities and limitations to medical device design. FDA requires HFE for devices where use error could cause or contribute to serious harm. The FDA HFE guidance (2016) and IEC 62366-1 define the expected process: task analysis, formative evaluations, critical task identification, validation testing with representative users, and residual risk assessment.

HFE documentation typically appears in 510(k), De Novo, and PMA submissions for devices with complex user interfaces or critical use tasks. A validation study with representative users performing critical tasks under simulated use conditions is the cornerstone deliverable. Use-related risk analysis per IEC 62366-1 drives which tasks are "critical" and therefore require validation. Poorly documented HFE is a common cause of FDA deficiency questions and resubmission.

Regulatory Context

This term appears most often in medical devices workflows where submission quality, regulatory evidence, and audit readiness depend on consistent language. It is commonly referenced alongside IEC 62366 1, 21 CFR 820, EU MDR.

FDA CDRHEMAHealth Canada

When This Matters

Formative usability studies identified five use errors addressed through interface redesign before validation.
HFE validation tested 30 representative users performing 12 critical tasks under simulated use conditions.

Common Mistakes

Using drug-only submission assumptions for device regulatory pathways.
Ignoring post-market obligations in pre-market planning.
Weak predicate and classification rationale in dossier narratives.

Related Regulations

IEC 62366 121 CFR 820EU MDR

Frequently Asked Questions

For devices where use error could cause or contribute to serious harm — essentially any device with a user interface controlling a critical function. FDA's HFE guidance lists considerations: complexity, user population, environment, consequences of error. When in doubt, perform HFE.

FDA guidance recommends minimum 15 representative users per distinct user group for validation testing. For devices with multiple user groups (e.g., clinicians, patients, caregivers), test each group separately. Exceeding the minimum strengthens statistical power.

For well-understood devices with extensive market use, documented use experience may support an abbreviated HFE approach — but FDA guidance still expects critical task identification and residual risk assessment. Novel device types typically need full validation.